<unk>  (INN, trade name Zykadia , from Novartis) is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014..Ceritinib is also sold under the brand name Spexib in few countries by Novartis .
Ceritinib
Axitinib
Abrocitinib
Sunitinib
Baricitinib
Erdafitinib
Upadacitinib
Dacomitinib